These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31573675)

  • 1. Delays in diagnosis of Duchenne muscular dystrophy: An evaluation of genotypic and sociodemographic factors.
    Counterman KJ; Furlong P; Wang RT; Martin AS
    Muscle Nerve; 2020 Jan; 61(1):36-43. PubMed ID: 31573675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy.
    Holtzer C; Meaney FJ; Andrews J; Ciafaloni E; Fox DJ; James KA; Lu Z; Miller L; Pandya S; Ouyang L; Cunniff C
    Genet Med; 2011 Nov; 13(11):942-7. PubMed ID: 21836521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of β
    Kelley EF; Cross TJ; Snyder EM; McDonald CM; ; Hoffman EP; Bello L
    Respir Res; 2019 Oct; 20(1):221. PubMed ID: 31619245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
    Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
    Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
    Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Clinical Characteristics of a National Cohort of Paediatric Duchenne Muscular Dystrophy Patients in Norway.
    Annexstad EJ; Fagerheim T; Holm I; Rasmussen M
    J Neuromuscul Dis; 2019; 6(3):349-359. PubMed ID: 31381525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
    Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
    Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).
    Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT
    J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of a cohort of Duchenne muscular dystrophy children seen between 1998 and 2014: An observational study from South India.
    Singh RJ; Manjunath M; Preethish-Kumar V; Polavarapu K; Vengalil S; Thomas PT; Thennarasu K; Gayathri N; Sekar D; Nashi S; Nalini A
    Neurol India; 2018; 66(1):77-82. PubMed ID: 29322964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.
    Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E;
    Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
    Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
    Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne muscular dystrophy in a developing country: challenges in management and genetic counseling.
    López-Hernández LB; Gómez-Díaz B; Escobar-Cedillo RE; Gama-Moreno O; Camacho-Molina A; Soto-Valdés DM; Anaya-Segura MA; Luna-Padrón E; Zúñiga-Guzmán C; Lopez-Hernández JA; Vázquez-Cárdenas NA; Sánchez-Chapul L; Rangel-Villalobos H; Canto P; López-Cardona MG; García S; Méndez-Covarrubias G; Coral-Vázquez RM
    Genet Couns; 2014; 25(2):129-41. PubMed ID: 25059011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?
    Soim A; Smith MG; Kwon JM; Mann JR; Thomas S; Ciafaloni E;
    J Child Neurol; 2018 Jul; 33(8):537-545. PubMed ID: 29759004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy.
    Mann JR; Zhang Y; McDermott S; Wang Y; Cai B; Conway KM; Paramsothy P; Royer J; Venkatesh S; Howard JF; Ciafaloni E;
    Neuroepidemiology; 2023; 57(2):90-99. PubMed ID: 36623491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hidden Disease: Delayed Diagnosis in Duchenne Muscular Dystrophy and Co-Occurring Conditions.
    Lee I; Turnage C; Sutyla R; Mitchell P; Lindahl H; Jesus A; Scharf RJ
    J Dev Behav Pediatr; 2022 Oct-Nov 01; 43(8):e541-e545. PubMed ID: 35943375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.
    Ramos E; Conde JG; Berrios RA; Pardo S; Gómez O; Mas Rodríguez MF
    J Neuromuscul Dis; 2016 May; 3(2):261-266. PubMed ID: 27854217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.
    Ricotti V; Ridout DA; Pane M; Main M; Mayhew A; Mercuri E; Manzur AY; Muntoni F;
    J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):149-55. PubMed ID: 25733532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.
    Fox DJ; Kumar A; West NA; DiRienzo AG; James KA; Oleszek J;
    J Child Neurol; 2015 Jan; 30(1):21-6. PubMed ID: 24682290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.